Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Lai

Showing results (271-280 of 282) with videos related to

Pageof 29
Sort By:
American Journal of Hematology|October 16, 2013
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progressionHsin-An Hou, Yuan-Yeh Kuo, Jih-Luh Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2026
Inhibitory potential of autologous neutralizing antibodies sets quantitative limits on the rebound-competent HIV-1 reservoirMauro A Garcia, Anna Farrell-Sherman, Beril Aydin, et al.
Ebiomedicine|March 14, 2024
Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimenRoux-Cil Ferreira, Steven J Reynolds, Adam A Capoferri, et al.
The Journal of Clinical Investigation|July 18, 2023
The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapyNatalie F McMyn, Joseph Varriale, Emily J Fray, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimenRoux-Cil Ferreira, Steven J Reynolds, Adam A Capoferri, et al.
The Journal of Clinical Investigation|January 5, 2023
Clonally expanded HIV-1 proviruses with 5'-leader defects can give rise to nonsuppressible residual viremiaJennifer A White, Fengting Wu, Saif Yasin, et al.
Plos One|March 21, 2015
Clinical and prognostic implications of Roundabout 4 (robo4) in adult patients with acute myeloid leukemiaYin-Kai Chen, Hsin-An Hou, Jih-Luh Tang, et al.
Nature Communications|June 8, 2026
5' leader defects drive persistent HIV-1 viremia on long-term ARTJulia R Box, Angelica Camilo-Contreras, Filippo Dragoni, et al.
The Lancet. HIV|July 11, 2020
Allogeneic bone marrow transplantation with post-transplant cyclophosphamide for patients with HIV and haematological malignancies: a feasibility studyChristine M Durand, Adam A Capoferri, Andrew D Redd, et al.
Journal of Neurointerventional Surgery|July 16, 2025
Renal function and post-thrombectomy outcomes and safety: nationwide registry studyKuo-Wei Chen, Yi-Chen Hsieh, Kun-Chang Tsai, et al.
Pageof 29

Showing results (271-280 of 282) with videos related to

Sort By:
Pageof 29
American Journal of Hematology|October 16, 2013
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progressionHsin-An Hou, Yuan-Yeh Kuo, Jih-Luh Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2026
Inhibitory potential of autologous neutralizing antibodies sets quantitative limits on the rebound-competent HIV-1 reservoirMauro A Garcia, Anna Farrell-Sherman, Beril Aydin, et al.
Ebiomedicine|March 14, 2024
Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimenRoux-Cil Ferreira, Steven J Reynolds, Adam A Capoferri, et al.
The Journal of Clinical Investigation|July 18, 2023
The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapyNatalie F McMyn, Joseph Varriale, Emily J Fray, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimenRoux-Cil Ferreira, Steven J Reynolds, Adam A Capoferri, et al.
The Journal of Clinical Investigation|January 5, 2023
Clonally expanded HIV-1 proviruses with 5'-leader defects can give rise to nonsuppressible residual viremiaJennifer A White, Fengting Wu, Saif Yasin, et al.
Plos One|March 21, 2015
Clinical and prognostic implications of Roundabout 4 (robo4) in adult patients with acute myeloid leukemiaYin-Kai Chen, Hsin-An Hou, Jih-Luh Tang, et al.
Nature Communications|June 8, 2026
5' leader defects drive persistent HIV-1 viremia on long-term ARTJulia R Box, Angelica Camilo-Contreras, Filippo Dragoni, et al.
The Lancet. HIV|July 11, 2020
Allogeneic bone marrow transplantation with post-transplant cyclophosphamide for patients with HIV and haematological malignancies: a feasibility studyChristine M Durand, Adam A Capoferri, Andrew D Redd, et al.
Journal of Neurointerventional Surgery|July 16, 2025
Renal function and post-thrombectomy outcomes and safety: nationwide registry studyKuo-Wei Chen, Yi-Chen Hsieh, Kun-Chang Tsai, et al.
Pageof 29